^Tsai, Hsiang-Lin; Tai, Chi-Jung; Huang, Ching-Wen; Chang, Fang-Rong; Wang, Jaw-Yuan. Efficacy of Low-Molecular-Weight Fucoidan as a Supplemental Therapy in Metastatic Colorectal Cancer Patients: A Double-Blind Randomized Controlled Trial. Marine Drugs. 2017-04-21, 15 (4). ISSN 1660-3397. PMC 5408268. PMID 28430159. doi:10.3390/md15040122.
^Fitton, J. Helen; Stringer, Damien N.; Park, Ah Young; Karpiniec, Samuel S. Therapies from Fucoidan: New Developments. Marine Drugs. 2019-10, 17 (10) [2023-08-13]. ISSN 1660-3397. doi:10.3390/md17100571. (原始内容于2023-08-13) (英语).
^Lin, Yuan; Qi, Xingsi; Liu, Hengjian; Xue, Kuijin; Xu, Shan; Tian, Zibin. The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations. Cancer Cell International. 2020-05-07, 20 (1). ISSN 1475-2867. PMC 7206694. PMID 32410882. doi:10.1186/s12935-020-01233-8. 引文格式1维护:PMC格式 (link)
^Yao, Yuan; Yim, Evelyn K. F. Fucoidan for cardiovascular application and the factors mediating its activities. Carbohydrate Polymers. 2021-10-15, 270. ISSN 0144-8617. doi:10.1016/j.carbpol.2021.118347(英语).